About   Help   FAQ
Tg(GFAP-cre/Esr1*,-lacZ)BSbk - Liver & Biliary System
Recombinase Activity Detail
Allele Information
Allele:
Tg(GFAP-cre/Esr1*,-lacZ)BSbk
transgene insertion B, Suzanne J Baker
Driver: GFAP
Type: Transgenic (Inducible, Recombinase)
Inducer: tamoxifen
Synonym: GFAP-CreERTM, GFAP-CreERTMB, Tg(GFAP-cre/Esr1)BSbk
Molecular description: This transgene consists of a 2.2 kb fragment of the human GFAP promoter, a cDNA encoding a fusion of cre and the ligand binding domain of the human estrogen receptor modified to bind 4-hydroxytamoxifen, but not endogenous estrogen, an IRES, a cDNA encoding beta-galactosidase, and SV40 intronic sequence and polyadenylation signal. Transgene expression, assessed by beta-gal activity, is seen in Bergmann glia, neuronal precursors in the dentate gyrus, and cells in the subventricular zone surrounding the lateral ventricle. When crossed to reporter mice occasional tamoxifen-independent Cre mediated recombination is seen primarily in Bergmann glial cells.
Find mice (IMSR): Mouse Strains: 0 strains available       Cell Lines: 0 lines available
Additional Tissues: Tg(GFAP-cre/Esr1*,-lacZ)BSbk activity also observed in:
alimentary system, head, nervous system, renal & urinary system, reproductive system
Recombinase Activity
Click heading to re-sort table.
Assays Genotypic Background Result Notes  
References
All for this allele: 7 reference(s)

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/19/2024
MGI 6.24
The Jackson Laboratory